Skip to the main content.

1 min read

Reducing CMC Risk Through TIME with KBI's Proven Analytical & Formulation Expertise

Speaker: Deanna Hunt, Senior Director of Business Development, Analytical and Formulation Sciences, KBI Biopharma 
Duration: ~20 min

Overview

CMC development is full of risk. Developers who outsource analytical services are constantly balancing that risk with cost, quality, and speed. KBI Biopharma, recipient of the CDMO Leadership Award, helps drug sponsors reduce risk and control costs through our Analytical and Formulation Sciences team, delivering accurate results right the first time, and on time.

Learn how KBI's TIME framework transforms analytical challenges into competitive advantages through:

  • Transparency that empowers your decisions through clear communication and real-time project visibility
  • Integration that simplifies your development and manufacturing with regulatory-ready data packages and collaborative core teams
  • Methods that de-risk your program using proven platform approaches and validated characterization techniques
  • Experience that accelerates your timelines with 29+ years supporting 1,400+ clients across diverse biologics
Who should watch:

CMC development teams, analytical scientists, regulatory affairs professionals, and project managers involved in outsourcing analytical services.

This presentation was part of Life Science Connect's analytical and formulation services capacity update session (July 2025)

 

Presenter

KBI_PortraitTemplate_Deanna

DEANNA HUNT

Senior Director of Business Development, Analytical and Formulation Sciences

   Linkedin Icon

 

Let's Connect

Interested in learning more about KBI Biopharma? Contact us today.

 

Rapid Timeline to Tox Starting with KBI Biopharma's SUREtechnology Platform™, Powered by Selexis®

1 min read

Rapid Timeline to Tox Starting with KBI Biopharma's SUREtechnology Platform™, Powered by Selexis®

Originally hosted at CPHI Milan, this presentation introduces the latest version of proprietary SURE CHO-M technology & an afucosylated host cell...

Read More
Breaking Barriers: Combining Cell Line Development Innovation with Improved Process Development Workflows to Streamline Path to FIH

1 min read

Breaking Barriers: Combining Cell Line Development Innovation with Improved Process Development Workflows to Streamline Path to FIH

Learn how KBI Biopharma’s SUREtechnology Platform™, powered by Selexis®, combines refined project workflows to accelerate the development of complex...

Read More
KBI Biopharma wins the Triangle Business Journal's 2017 Life Sciences Company of The Year Award

KBI Biopharma wins the Triangle Business Journal's 2017 Life Sciences Company of The Year Award

KBI Biopharma is honored to have been recognized as a winner of The 2017 Life Sciences Company of the Year by Triangle Business Journal. This award ...

Read More